Found "Medical Procedures": 262 results
Sort by
Relevance

Multi-criteria decision analysis to prioritize health interventions: Capitalizing on first experiences. (2010)

Multi-criteria decision analysis to prioritize health interventions: Capitalizing on first experiences. Rob Baltussen1, Sitapon Youngkong11,2, Francesco Paolucci3, Louis Niessen4 1 Department of Primary and Community Care, Radboud University Nijmegen Medical Center, The Netherlands 2 Health I

18th HTAsiaLink Newsletter: The Role of HTA in the New Normal: Driving the post-COVID health systems through evidence-informed decisions

The 10th HTAsiaLink Annual Conference is the first physical conference after the pandemic hit for HTAsiaLink network. Under the theme ‘The Role of HTA in the New Normal: Driving the post-COVID health systems through evidence-informed decisions,’ a broad range of discussions were sparked and would co

The EVIDEM framework and its usefulness for priority setting across a broad range of health interventions.(2011)

The EVIDEM framework and its usefulness for priority setting across a broad range of health interventions Download at http://www.resource-allocation.com/content/9/1/8 Sitaporn Youngkong1,2*, Noor Tromp1† and Dereck Chitama1,3† * Corresponding author: Sitaporn Youngkong [email protected]

A cost – utility analysis of alternative drug regimens for newly diagnosed severe lupus nephritis patients in Thailand. (2013)

A cost–utility analysis of alternative drug regimens for newly diagnosed severe lupus nephritis patients in Thailand. Adun Mohara1, Román Pérez Velasco1, Naiyana Praditsitthikorn1,2, Yingyos Avihingsanon3 and Yot Teerawattananon1 1Health Intervention and Technology Assessment Program (HITAP),

Health Care Coverage Decision Making in Low- and Middle-Income Countries: Experiences from 25 Coverage Schemes (2014)

Hialy Gutierrez, MPH,1,2 Ashwini Shewade, MS, MSc,1 Minghan Dai, MPH,1 Pedro Mendoza-Arana, MD, MSc,3 Octavio Go´mez-Dante´s, MD, MPH,4 Nishant Jain, PhD,5 Irma Khonelidze, MPA,6 Juliet Nabyonga-Orem, MD, MSc,7 Karima Saleh, PhD,8 Yot Teerawattananon, MD, PhD,9 Sania Nishtar, SI, PhD,10 and John Hor

How to meet the demand for good quality renal dialysis as part of universal health coverage in resource-limited settings? (2016)

Yot Teerawattananon, Alia Luz* , Songyot Pilasant, Suteenoot Tangsathitkulchai, Sarocha Chootipongchaivat, Nattha Tritasavit, Inthira Yamabhai and Sripen Tantivess Abstract Background: It is very challenging for resource-limited settings to introduce universal health coverage (UHC), particular

Coverage Decisions and the Court: A Public Health Perspective on Glucosamine Reimbursement in Thailand (2016)

Sripen Tantivess & Viroj Tangcharoensathien Abstract Thailand achieves universal health coverage through the introduction of 3 benefit schemes: the Civil Servant Medical Benefit Scheme (CSMBS), Social Security Scheme, and Universal Coverage Scheme. The primary benefit package of these sche

The influence of cost-per-DALY information in health prioritisation and desirable features for a registry: a survey of health policy experts in Vietnam, India and Bangladesh (2016)

Background Economic evaluation has been implemented to inform policy in many areas, including coverage decisions, technology pricing, and the development of clinical practice guidelines. However, there are barriers to evidence-based policy in low- and middle-income countries (LMICs) that include li

Economic cost of tobacco-related cancers in Sri Lanka

Abstract Introduction Cancer has a high mortality rate and morbidity burden in Sri Lanka. This study estimated the economic cost of smoking and smokeless tobacco (ST) related to cancers in Sri Lanka in 2015. Methods Prevalence-based cost of illness is calculated according to the guidelines o

The influence of cost-per-DALY information in health prioritisation and desirable features for a registry: a survey of health policy experts in Vietnam, India and Bangladesh

Abstract BACKGROUND: Economic evaluation has been implemented to inform policy in many areas, including coverage decisions, technology pricing, and the development of clinical practice guidelines. However, there are barriers to evidence-based policy in low- and middle-income countries (LMICs) th
10 / Page